查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1363318

核酸增幅检查市场规模、份额、趋势分析报告：按类型、用途、最终用途、地区和细分市场预测，2023-2030

Nucleic Acid Amplification Testing Market Size, Share & Trends Analysis Report By Type (PCR, INAAT), By Application (Infectious Disease Testing, Oncology Testing), By End-use, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

核酸增幅检查市场成长与趋势：

Grand View Research, Inc.最新报告显示，预计2030年全球核酸增幅检查市场规模将达192亿美元，2023年至2030年年复合成长率为12.2%。

人们对慢性病和感染疾病早期检测的认识不断提高，以及 PCR 技术的新技术进步，要素将显着推动市场成长。此外，全球范围内流感、肝炎和性行为感染等感染疾病的日益流行预计将增加对核酸增幅检查的需求并对市场成长产生积极影响。

近年来，核酸增幅检查吸引了大量投资，因为它们适用于诊断各种病理，包括癌症等危及生命的病理。津贴，公共投资的美国基因的开发。

此外，核酸增幅检查的高效率和准确性使该技术比基于培养的鉴定等传统诊断选项更受青睐。这些特征正在推动核酸增幅检查技术的发展。

COVID-19 增加了对快速、准确的检测方法的需求，包括核酸增幅检查，以检测 SARS-CoV-2 病毒。该市场的主要参与者开发了新产品，例如基于恒温核酸增幅技术的测试，以满足快速即时测试的高需求。

例如，2020 年 3 月，雅培实验室的雅培 ID NOW COVID-19 检测获得了紧急使用核准(EUA)，可在 5 分钟内提供阳性结果，并在 13 分钟内提供阴性结果。这些由疫情推动的策略倡议预计将在不久的将来推动市场成长。

核酸增幅检查市场报告亮点

  • 聚合酶炼式反应（PCR）检测在2022年占据最大份额，为66.7%，因为它是一种由于其高精度和多重功能而能够检测多种病原体的检测类型。
  • 依用途分，感染疾病占比最大，2022年为46.4%。全球日益流行的感染疾病以及核酸扩增技术提供的高效检测方案正在推动这一领域的发展。
  • 北美地区占比最大，2022年为37.1%。这是因为该地区拥有成熟的医疗保健部门和雅培实验室 (Abbott Laboratories)、Illumina, Inc. 和 Bio-Rad Laboratories, Inc. 等主要参与者。
  • 由于医疗保健投资的增加和早期疾病诊断中越来越多地采用核酸增幅检查，中心实验室和标准实验室最终用途用途市场在 2022 年占据了 41.9%的市场占有率。

目录

第1章调查方法和范围

第2章执行摘要

第3章核酸增幅检查市场变数、趋势与范围

  • 市场体系预测
    • 母市场预测
    • 相关/附随市场预测
  • 普及和成长预测图
  • 市场动态
    • 市场促进因素分析
    • 市场抑制因素分析
  • 核酸增幅检查市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第4章核酸增幅检查：依类型估计与趋势分析

  • 核酸增幅检查市场：要点
  • 核酸增幅检查市场：2022 年和 2030 年趋势和市场占有率分析
  • 聚合酶连锁反应（PCR）测试
  • 恒温核酸增幅技术（INAAT）测试
  • 连接酶链反应（LCR）测试

第5章核酸增幅检查：依用途进行估算与趋势分析

  • 核酸增幅检查市场：要点
  • 核酸增幅检查市场：2022 年和 2030 年趋势和市场占有率分析
  • 传染病检查
  • 肿瘤学测试
  • 遗传和粒线体疾病检测

第6章核酸扩增试验：依最终用途进行估算与趋势分析

  • 核酸增幅检查市场：要点
  • 核酸增幅检查市场：2022 年和 2030 年趋势和市场占有率分析
  • 医院
  • 中央与参考实验室
  • 其他的

第7章核酸增幅检查市场：区域估计与趋势分析

  • 区域预测
  • 按地区分類的核酸增幅检查市场：要点
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第8章竞争形势

  • 主要市场参与企业的最新趋势和影响分析
  • 市场参与企业分类
    • F. Hoffmann-La Roche Ltd
    • Becton, Dickinson and Company
    • Danaher Corporation
    • Abbott Laboratories
    • Illumina, Inc.
    • Siemens Healthineers
    • bioMerieux SA
    • Novartis AG
    • Bio-Rad Laboratories, Inc.
    • Seegene Inc.
Product Code: GVR-1-68038-388-1

Nucleic Acid Amplification Testing Market Growth & Trends:

The global nucleic acid amplification testing market size is expected to reach USD 19.2 billion by 2030, registering a CAGR of 12.2% from 2023 to 2030, according to a new report by Grand View Research, Inc.. Rising awareness regarding early detection of chronic and infectious diseases, and emerging technological advancements in PCR technology are the factors expected to significantly drive the market growth. In addition, the global rise in the prevalence of infectious diseases such as influenza, hepatitis, and sexually transmitted infections is anticipated to increase the demand for nucleic acid amplification testing and positively affect market growth.

Nucleic acid amplification testing has witnessed a high amount of investment in recent years due to its applicability to diagnose a variety of disease conditions, including life-threatening conditions such as cancer. For instance, the development of Cepheid's Gene Xpert technology involved a total public investment of over USD 252.0 million, including grants of more than USD 56.0 million from the National Institutes of Health, and around USD 73.0 million from other U.S. government departments.

Moreover, the high efficiency and accuracy of nucleic acid amplification testing have led to an increasing preference for the technique over traditional diagnostic options, such as culture-based identification. These attributes are boosting the growth of nucleic acid amplification testing technologies.

COVID-19 has increased demand for rapid and accurate testing methods, including nucleic acid amplification testing, for the detection of the SARS-CoV-2 virus. Key players involved in the market have developed new product offerings, such as isothermal nucleic acid amplification technology-based tests, to meet the high demand for rapid and point-of-care testing.

For instance, in March 2020, Abbott Laboratories received Emergency Use Authorization (EUA) for its Abbott ID NOW COVID-19 test which can deliver positive results within five minutes and negative results within 13 minutes. Such strategic initiatives fueled by the pandemic are expected to boost market growth in the near future.

Nucleic Acid Amplification Testing Market Report Highlights:

  • Polymerase Chain Reaction (PCR) tests held the largest share of 66.7% in 2022 as the testing type allows for the high accuracy and multiplexing capabilities for the detection of a broad range of pathogens
  • By application, infectious diseases accounted for the largest share of 46.4% in 2022. The rising prevalence of the infectious disease globally and efficient testing alternatives offered by nucleic acid amplification techniques are driving the segment
  • North America held the largest share of 37.1% in 2022, due to the presence of an established healthcare sector and key players such as Abbott Laboratories; Illumina, Inc.; Bio-Rad Laboratories, Inc., and others in the region
  • Central and reference laboratories end-use segment dominated the market in 2022 with a market share of 41.9% in 2022 due to the increasing healthcare investments and rising adoption of nucleic acid amplification tests for early disease diagnosis

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Type
    • 1.1.2. Application
    • 1.1.3. End-use
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. Application outlook
    • 2.2.3. End-use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Nucleic Acid Amplification Testing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Analysis
    • 3.3.2. Market Restraint Analysis
  • 3.4. Nucleic Acid Amplification Testing Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic Landscape

Chapter 4. Nucleic Acid Amplification Testing: Type Estimates & Trend Analysis

  • 4.1. Nucleic Acid Amplification Testing Market: Key Takeaways
  • 4.2. Nucleic Acid Amplification Testing Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Polymerase Chain Reaction (PCR) Tests
    • 4.3.1. Polymerase chain reaction (PCR) tests market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Isothermal Nucleic Acid Amplification Technology (INAAT) Tests
    • 4.4.1. Isothermal nucleic acid amplification technology (INAAT) tests market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Ligase Chain Reaction (LCR) Tests
    • 4.5.1. Ligase Chain Reaction (LCR) Tests market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Nucleic Acid Amplification Testing: Application Estimates & Trend Analysis

  • 5.1. Nucleic Acid Amplification Testing Market: Key Takeaways
  • 5.2. Nucleic Acid Amplification Testing Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Infectious Disease Testing
    • 5.3.1. Infectious disease testing market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.3.2. Covid-19 Testing
      • 5.3.2.1. Covid-19 testing market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.3.3. Mosquito Borne Disease Testing
      • 5.3.3.1. Mosquito borne disease testing market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.3.4. Influenza Testing
      • 5.3.4.1. Influenza testing market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.3.5. Sexually Transmitted Infectious Testing
      • 5.3.5.1. Sexually transmitted infectious testing market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.3.6. Hepatitis Testing
      • 5.3.6.1. Hepatitis testing market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.3.7. Tuberculosis Testing
      • 5.3.7.1. Tuberculosis testing market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.3.8. Others
      • 5.3.8.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Oncology Testing
    • 5.4.1. Oncology testing market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Genetic & Mitochondrial Disease Testing
    • 5.5.1. Genetic & mitochondrial disease testing market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Nucleic Acid Amplification Testing: End Use Estimates & Trend Analysis

  • 6.1. Nucleic Acid Amplification Testing Market: Key Takeaways
  • 6.2. Nucleic Acid Amplification Testing Market: Movement & Market Share Analysis, 2022 & 2030
  • 6.3. Hospitals
    • 6.3.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.4. Central and Reference Laboratories
    • 6.4.1. Central and reference Laboratories market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5. Others
    • 6.5.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Nucleic Acid Amplification Testing Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Outlook
  • 7.2. Nucleic Acid Amplification Testing Market by Region: Key Takeaways
  • 7.3. North America
    • 7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.3. France
      • 7.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.6. Denmark
      • 7.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.7. Sweden
      • 7.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.8. Norway
      • 7.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.2. China
      • 7.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.3. India
      • 7.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.5. Thailand
      • 7.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.6. South Korea
      • 7.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.2. Mexico
      • 7.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.7. MEA
    • 7.7.1. South Africa
      • 7.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Market Participant Categorization
    • 8.2.1. F. Hoffmann-La Roche Ltd
      • 8.2.1.1. Company overview
      • 8.2.1.2. Financial performance
      • 8.2.1.3. Product benchmarking
      • 8.2.1.4. Strategic initiatives
    • 8.2.2. Becton, Dickinson and Company
      • 8.2.2.1. Company overview
      • 8.2.2.2. Financial performance
      • 8.2.2.3. Product benchmarking
      • 8.2.2.4. Strategic initiatives
    • 8.2.3. Danaher Corporation
      • 8.2.3.1. Company overview
      • 8.2.3.2. Financial performance
      • 8.2.3.3. Product benchmarking
      • 8.2.3.4. Strategic initiatives
    • 8.2.4. Abbott Laboratories
      • 8.2.4.1. Company overview
      • 8.2.4.2. Financial performance
      • 8.2.4.3. Product benchmarking
      • 8.2.4.4. Strategic initiatives
    • 8.2.5. Illumina, Inc.
      • 8.2.5.1. Company overview
      • 8.2.5.2. Financial performance
      • 8.2.5.3. Product benchmarking
      • 8.2.5.4. Strategic initiatives
    • 8.2.6. Siemens Healthineers
      • 8.2.6.1. Company overview
      • 8.2.6.2. Financial performance
      • 8.2.6.3. Product benchmarking
      • 8.2.6.4. Strategic initiatives
    • 8.2.7. bioMerieux SA
      • 8.2.7.1. Company overview
      • 8.2.7.2. Financial performance
      • 8.2.7.3. Product benchmarking
      • 8.2.7.4. Strategic initiatives
    • 8.2.8. Novartis AG
      • 8.2.8.1. Company overview
      • 8.2.8.2. Financial performance
      • 8.2.8.3. Product benchmarking
      • 8.2.8.4. Strategic initiatives
    • 8.2.9. Bio-Rad Laboratories, Inc.
      • 8.2.9.1. Company overview
      • 8.2.9.2. Financial performance
      • 8.2.9.3. Product benchmarking
      • 8.2.9.4. Strategic initiatives
    • 8.2.10. Seegene Inc.
      • 8.2.10.1. Company overview
      • 8.2.10.2. Financial performance
      • 8.2.10.3. Product benchmarking
      • 8.2.10.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 North America nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
  • Table 3 North America nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
  • Table 4 North America nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 5 North America nucleic acid amplification testing market, by region, 2018 - 2030 (USD Million)
  • Table 6 U.S. nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
  • Table 7 U.S. nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
  • Table 8 U.S. nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 9 Canada nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
  • Table 10 Canada nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
  • Table 11 Canada nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 12 Europe nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
  • Table 13 Europe nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
  • Table 14 Europe nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 15 Europe nucleic acid amplification testing market, by region, 2018 - 2030 (USD Million)
  • Table 16 Germany nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
  • Table 17 Germany nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
  • Table 18 Germany nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 19 UK nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
  • Table 20 UK nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
  • Table 21 UK nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 22 France nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
  • Table 23 France nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
  • Table 24 France nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 25 Italy nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
  • Table 26 Italy nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
  • Table 27 Italy nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 28 Spain nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
  • Table 29 Spain nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
  • Table 30 Spain nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 31 Denmark nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
  • Table 32 Denmark nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
  • Table 33 Denmark nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 34 Sweden nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
  • Table 35 Sweden nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
  • Table 36 Sweden nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 37 Norway nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
  • Table 38 Norway nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
  • Table 39 Norway nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific nucleic acid amplification testing market, by region, 2018 - 2030 (USD Million)
  • Table 44 Japan nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
  • Table 45 Japan nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
  • Table 46 Japan nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 47 China nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
  • Table 48 China nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
  • Table 49 China nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 50 India nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
  • Table 51 India nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
  • Table 52 India nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 53 Australia nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
  • Table 54 Australia nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
  • Table 55 Australia nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 56 Thailand nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
  • Table 57 Thailand nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
  • Table 58 Thailand nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 59 South Korea nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
  • Table 60 South Korea nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
  • Table 61 South Korea nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 62 Latin America nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
  • Table 63 Latin America nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
  • Table 64 Latin America nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 65 Latin America nucleic acid amplification testing market, by region, 2018 - 2030 (USD Million)
  • Table 66 Brazil nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
  • Table 67 Brazil nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
  • Table 68 Brazil nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 69 Mexico nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
  • Table 70 Mexico nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
  • Table 71 Mexico nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 72 Argentina nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
  • Table 73 Argentina nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
  • Table 74 Argentina nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 75 Middle East and Africa nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
  • Table 76 Middle East and Africa nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
  • Table 77 Middle East and Africa nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 78 Middle East and Africa nucleic acid amplification testing market, by region, 2018 - 2030 (USD Million)
  • Table 79 South Africa nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
  • Table 80 South Africa nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
  • Table 81 South Africa nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
  • Table 84 Saudi Arabia nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 85 UAE nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
  • Table 86 UAE nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
  • Table 87 UAE nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 88 Kuwait nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
  • Table 89 Kuwait nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
  • Table 90 Kuwait nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Nucleic acid amplification testing: Market outlook
  • Fig. 9 Nucleic acid amplification testing: Competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Nucleic acid amplification testing market driver impact
  • Fig. 15 Nucleic acid amplification testing market restraint impact
  • Fig. 16 Nucleic acid amplification testing market strategic initiatives analysis
  • Fig. 17 Nucleic acid amplification testing market: Type movement analysis
  • Fig. 18 Nucleic acid amplification testing market: Type outlook and key takeaways
  • Fig. 19 Polymerase chain reaction (PCR) tests market estimates and forecasts, 2018 - 2030
  • Fig. 20 Isothermal nucleic acid amplification technology (INAAT) tests market estimates and forecasts, 2018 - 2030
  • Fig. 21 Ligase chain reaction (LCR) tests market estimates and forecasts, 2018 - 2030
  • Fig. 22 Nucleic acid amplification testing market: Application movement analysis
  • Fig. 23 Nucleic acid amplification testing market: Application outlook and key takeaways
  • Fig. 24 Infectious disease testing market estimates and forecasts, 2018 - 2030
  • Fig. 25 Covid-19 testing market estimates and forecasts, 2018 - 2030
  • Fig. 26 Mosquito borne disease testing market estimates and forecasts, 2018 - 2030
  • Fig. 27 Influenza testing market estimates and forecasts, 2018 - 2030
  • Fig. 28 Sexually transmitted infection testing market estimates and forecasts, 2018 - 2030
  • Fig. 29 Hepatitis testing market estimates and forecasts, 2018 - 2030
  • Fig. 30 Tuberculosis testing market estimates and forecasts, 2018 - 2030
  • Fig. 31 Others testing market estimates and forecasts, 2018 - 2030
  • Fig. 32 Oncology testing market estimates and forecasts, 2018 - 2030
  • Fig. 33 Genetic & mitochondrial disease testing market estimates and forecasts, 2018 - 2030
  • Fig. 34 Others testing market estimates and forecasts, 2018 - 2030
  • Fig. 35 Nucleic acid amplification testing market: End-use movement analysis
  • Fig. 36 Nucleic acid amplification testing market: End-use outlook and key takeaways
  • Fig. 37 Hospitals market estimates and forecasts, 2018 - 2030
  • Fig. 38 Central and reference laboratories market estimates and forecasts, 2018 - 2030
  • Fig. 39 Others market estimates and forecasts, 2018 - 2030
  • Fig. 40 Global nucleic acid amplification testing market: Regional movement analysis
  • Fig. 41 Global nucleic acid amplification testing market: Regional outlook and key takeaways
  • Fig. 42 North America market estimates and forecasts, 2018 - 2030
  • Fig. 43 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 44 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 45 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 46 UK market estimates and forecasts, 2018 - 2030
  • Fig. 47 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 48 France market estimates and forecasts, 2018 - 2030
  • Fig. 49 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 50 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 51 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 52 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 53 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 54 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 55 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 56 China market estimates and forecasts, 2018 - 2030
  • Fig. 57 India market estimates and forecasts, 2018 - 2030
  • Fig. 58 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 59 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 60 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 61 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 62 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 63 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 64 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 65 Middle East and Africa. market estimates and forecasts, 2018 - 2030
  • Fig. 66 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 67 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 68 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 69 Kuwait market estimates and forecasts, 2018 - 2030